These compounds may interact with:
Corticotropin-releasing factor receptor 1
Potentially involved in: osteoporosis; carcinoma; chronic kidney disease; post-traumatic stress disorder; irritable bowel syndrome; alcohol dependence; panic disorder; major depressive disorder; koolen de vries syndrome; generalized anxiety disorder; invasive aspergillosis; substance abuse; alcoholic intoxication, chronic; anorexia; anxiety disorders; bipolar disorder; mental depression; depressive disorder; contact dermatitis; psychotic disorders
Disease data sourced from Pharos.